The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

The AI Act sets a global precedent for responsible AI development—balancing innovation with accountability and ensuring AI technologies uphold safety, transparency, and fundamental rights

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

The Artificial Intelligence Act (Regulation (EU) 2024/1689) is the European Union’s first-ever legislation to comprehensively regulate AI systems. It establishes a risk-based framework to ensure AI technologies are developed and deployed responsibly, balancing innovation with accountability.

This whitepaper provides an essential overview of the AI Act, helping businesses, developers, and public authorities understand the law’s key requirements, who it applies to, and how to prepare for compliance.

Discover the classification of AI systems, specific obligations for high-risk and general-purpose AI models, enforcement mechanisms, penalties, and the upcoming implementation timelines.

Stay ahead of the curve and equip yourself with the knowledge needed to navigate AI regulation confidently.

 

Key Topics Covered

  • What the Artificial Intelligence Act is and why it is needed
  • Who must comply: providers, deployers, importers, distributors, authorised representatives
  • Key definitions: AI systems, systemic risk, general-purpose AI models
  • Risk-based classification of AI systems: Unacceptable, High, Limited, and Minimal risk
  • Detailed obligations for high-risk AI systems, including quality management, transparency, human oversight, and cybersecurity
  • Additional requirements for General-Purpose AI Models with systemic risk
  • Penalties for non-compliance, including fines up to €35 million
  • Practical steps businesses and developers should take now to prepare
  • Important deadlines and the AI Act’s implementation timeline

Learn about AI system risk classifications, compliance obligations, penalties, and timelines and stay ahead of EU AI regulations.

Download your AI Act Compliance Whitepaper

 

Hero Image AI Act WP MedTech

Who this is for

This whitepaper is designed for:

    • AI system developers and providers launching solutions within the EU

    • Organisations deploying AI technologies in operations or services

    • Medical device manufacturers integrating AI into their products

    • Compliance, legal, and regulatory professionals overseeing AI governance

    • Public sector bodies and private organisations using AI in decision-making

    • Anyone seeking to understand and implement the AI Act’s requirements

View our other resources and company news

mock inspection blog header Case Study

GMP Consultancy for a New Cannabis Manufacturing Plant

A start up cannabis manufacturer partnered with Rephine to design a GMP compliant facility, implement a practical Quality Management System and prepare for EU GMP ...
Read More
QMS IMP Header image case study May 25 Article

How an Internal Services Audit Can Maximise Your Regulatory Compliance

Internal services audits play a critical role in maintaining GMP compliance and driving continuous improvement. This article explores how structured gap assessments, internal audits and ...
Read More
GMP Raising the bar Blog series Header image May 25 Article

Effective QMS Management Post-Go-Live: Strategies for Governance, Releases, and Continuous Improvement

After QMS go live, compliance and performance depend on strong governance, structured release management and continuous improvement. Learn how to sustain control, adoption and long ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

GMP Consultancy for a New Manufacturing Plant

With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Article

Why Quality Can No Longer Live in Silos

Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
QMS IMP Header image Blog case study May 25 Article

Why Most QMS Implementations Fail to Deliver Long-Term Value

Implementing a QMS is more than deploying software. Learn why most QMS implementations fall short, and what successful life sciences teams do differently to achieve ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Driving Global QMS Harmonisation for a Pharmaceutical Company

This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
CSV Blog

IT Quality Assurance in Regulated Life Sciences: Key Insights

IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan General

Practical compliance and inspection readiness for UK pharmaceutical quality systems

Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards